Siligmueller & Norvid Wealth Advisors’s Pfizer PFE Stock Holding History

Siligmueller & Norvid Wealth Advisors’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	$266K	Buy	+10,437	New	+$258K	0.12%	134

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Siligmueller & Norvid Wealth Advisors's PFE Position: Q3 2025 in Review

Siligmueller & Norvid Wealth Advisors opened a new position in Pfizer (PFE) in Q3 2025: 10,437 shares worth $266K. The stake represents 0.12% of the portfolio and ranks #134 among its holdings.

2,811 funds tracked by Wall St. Rank hold PFE as of Q3 2025.

Siligmueller & Norvid Wealth Advisors held 10,437 shares of Pfizer worth $266K as of Q3 2025.
Pfizer was a new Siligmueller & Norvid Wealth Advisors position in Q3 2025.
Pfizer made up 0.12% of Siligmueller & Norvid Wealth Advisors's portfolio in Q3 2025, its #134 holding.
2,811 funds tracked by Wall St. Rank held Pfizer as of Q3 2025.

Based on Siligmueller & Norvid Wealth Advisors's 13F filing for Q3 2025, filed 10 Nov 2025.